Perimenopause Treatment Options: What Works, What Doesn’t, and How I Decide

Open notebook and pen, a cup of herbal tea, reading glasses and a sprig of greenery on a wooden table by a window

Perimenopause treatment is not one medicine for one hormone number. It begins with a diagnosis, a clear target and an honest discussion of benefit and risk. Hot flashes, changing periods, poor sleep, low mood, vaginal symptoms and low libido may overlap, but they do not all respond to the same treatment. Here is how I sort the options.

When Perimenopause Starts, and What It Looks Like in Your Early Forties

Perimenopause is defined by the menstrual cycle, not by a birthday. Under the STRAW+10 staging that clinicians use, the early transition begins when cycle length starts to vary by seven days or more from one cycle to the next. The late transition is marked by gaps of sixty days or longer. The final period is only known in hindsight, twelve months after it happens.

In the United States the final period arrives at a median age of about 51, and the transition usually begins in the mid-forties. In the Study of Women’s Health Across the Nation, the transition lasted a median of just over four years for women who entered it latest and more than eight years for those who entered it youngest. Starting early does not mean finishing early.

So symptoms at 42 or 44, with periods that still arrive, are common rather than unusual. The typical early picture is a cycle that shortens or drifts, a heavier or longer period, night sweats a few nights a month, lighter sleep and a change in mood or patience. Prolonged or heavy bleeding is frequent at this stage; in the same cohort, roughly three in four women recorded a period of ten days or longer at least three times. That is exactly why bleeding is still evaluated rather than assumed.

Two ages change my approach. Under 45, cycle changes get a further work-up before anything is attributed to perimenopause. Under 40, loss of periods is treated as primary ovarian insufficiency until proven otherwise, which is a different diagnosis with its own treatment and referral.

The Diagnosis, Briefly

For a woman 45 or older with a typical pattern, the diagnosis is clinical. A single hormone level cannot confirm or exclude it, because levels swing from week to week during the transition. Labs answer specific questions, such as thyroid, iron, pregnancy or a mimic suggested by the history, and unexplained bleeding is investigated before anything is treated.

I describe the full work-up, the fees and the follow-up schedule on the perimenopause and menopause treatment page. This article is about the choices that follow.

Hormone Therapy: What It Does Well, and What It Does Not

Systemic menopausal hormone therapy is the most effective treatment for hot flashes and night sweats. For many healthy women younger than 60 or within ten years of menopause onset, the benefit-risk profile is favorable when symptoms are bothersome and there is no contraindication. Risk is not one number: it changes with age, time since menopause, dose, route, duration, whether a uterus is present and personal medical history.

What it does well: hot flashes and night sweats, sleep when night sweats are what wake you, vaginal dryness, and bone density while it is used. What it does not do: it is not prescribed to prevent heart disease or dementia, it is not a weight treatment, and mood or sleep problems with another cause do not resolve because estrogen was added.

The prescribing choices, such as route, dose, progesterone for a woman with a uterus, FDA-approved products and why I do not use pellets, are covered on the treatment page. The short version: an estradiol patch with oral micronized progesterone is my usual starting point, patches appear to carry less clot risk than tablets, and a history of certain cancers, blood clots, stroke, heart attack or significant liver disease can change or rule out systemic treatment.

Continuing treatment is reviewed periodically rather than set to an automatic stop date. The 2024 review of the Women’s Health Initiative trials confirmed two things at once: for symptomatic women under 60 the early alarm was overstated, and hormone therapy is still not a strategy for preventing chronic disease.

If You Are Still Having Periods

Having periods does not rule out treatment. Perimenopausal symptoms often begin before cycles become irregular. The plan depends on bleeding pattern, pregnancy risk and whether contraception is also needed. Menopausal hormone therapy is not contraception.

Combined hormonal contraception can sometimes address contraception, cycle control and hot flashes in an appropriate candidate. Other women use an estradiol-based menopause regimen with separate contraception. An intrauterine device (IUD) can be part of some plans. I do not place IUDs, so that part is arranged with your gynecologist.

New or troublesome bleeding should not simply be treated as expected perimenopause. The timing, volume, duration and risk factors decide whether investigation comes first.

Sleep in Perimenopause

Sleep is the complaint I hear most after hot flashes, and it usually has more than one cause. In the Study of Women’s Health Across the Nation, trouble sleeping rose steadily across the transition, and the rise was not explained by night sweats alone. Hormones, mood, age and habits each contribute.

So the first question is what is waking you. Night sweats that wake you point toward hormone therapy or, if hormones are not an option, gabapentin at night or fezolinetant. Waking at three in the morning with a racing mind and no sweats is usually insomnia, and the treatment with the best evidence is cognitive behavioral therapy for insomnia. The American Academy of Sleep Medicine recommends it first, ahead of sleeping pills. Loud snoring, morning headaches and daytime sleepiness raise the question of sleep apnea, which becomes more common after menopause and is not treated by hormones.

I refer for cognitive behavioral therapy when the pattern fits. Hormone therapy is not prescribed for sleep on its own; it earns its place when night sweats are the driver.

Non-Hormonal Medicines

Hormone therapy is not suitable or desirable for everyone. Evidence-based nonhormonal medicines for hot flashes include certain SSRIs and SNRIs, gabapentin, oxybutynin and fezolinetant. These are different drug classes with different side effects, interactions and monitoring needs; they are not interchangeable.

An SSRI or SNRI may make particular sense when mood or anxiety symptoms coexist. Gabapentin can be useful when nighttime symptoms dominate, although sedation or dizziness can limit it. Oxybutynin has anticholinergic effects that deserve careful review. Fezolinetant acts on the brain’s temperature-regulation pathway and requires attention to liver monitoring and interacting medicines.

Cognitive behavioral therapy has evidence for reducing the burden of hot flashes and for treating insomnia. I refer for it when the symptom and the client’s preference fit.

Low Libido and Vaginal Symptoms

Vaginal dryness, burning, discomfort with sex and some urinary symptoms belong to the genitourinary syndrome of menopause. They often become more persistent after periods stop. Moisturizers and lubricants can help, but low-dose local vaginal estrogen is often the more direct treatment when symptoms continue. It can be considered even when systemic hormone therapy is not otherwise needed.

Low desire is different. Relationship factors, pain, sleep, mood, medication and health conditions all matter. After those contributors are assessed, physiological-dose transdermal testosterone can be considered for low sexual desire, with informed discussion and monitoring. The evidence-based indication is narrow. Testosterone is not a general remedy for energy, body composition, mood or cognitive complaints.

Vaginal symptoms and low desire can occur together, but treating discomfort first may change the libido picture. That is why I do not put both complaints into one prescription automatically.

Supplements, Over-the-Counter Products, and What Does Not Work

This is the section people search for most, so I will be direct. The Menopause Society’s 2023 review of nonhormone options examined the supplements and herbal products sold for menopause and did not recommend any of them for hot flashes. Black cohosh, the most studied, showed no dependable benefit over placebo across sixteen trials in the Cochrane review. Soy foods and isoflavone extracts have inconsistent results, and the Society does not recommend them either. Evening primrose oil, wild yam creams, maca and the multi-ingredient “menopause support” blends have less evidence than any of these.

None of this makes a supplement dangerous by default, but “natural” is not a safety category. Products vary from bottle to bottle, some interact with prescription medicines, and a few have been linked to reports of liver injury. If you take one, tell me what it is.

Perimenopause weight gain deserves the same honesty. No supplement has been shown to prevent or reverse it. What changes at midlife is where fat is stored and how much muscle is kept, so the levers that work are unglamorous: protein at each meal, regular resistance training, sleep and alcohol kept low. Hormone therapy is not a weight-loss treatment. When weight itself is the medical problem, that is a separate conversation on the medical weight loss page.

A treatment can contain a real hormone and still be marketed beyond the evidence. Saliva or urine hormone panels do not reliably tell us the dose a woman with typical symptoms needs; symptoms, history and response matter more than a target number. Compounded products may suit a specific need or an informed preference, but they are not inherently safer than FDA-approved ones. Cognitive behavioral therapy and clinical hypnosis do have evidence for reducing the burden of hot flashes. Exercise and yoga do not reliably reduce hot flashes, although they still matter for heart, bone, muscle and sleep.

How I Decide

I work through four questions. First, what is the symptom we are treating? Second, how likely is it to be driven by the menopause transition? Third, what does your history change about the available choices? Fourth, what level of treatment feels proportionate to you?

  1. Define one or two outcomes that would make treatment worthwhile
  2. Identify contraindications, bleeding that needs investigation and important mimics
  3. Compare hormone, nonhormonal and local options in the context of your preferences
  4. Choose a starting dose and monitoring plan, then reassess the actual response

Fees, what the first visit includes and the follow-up schedule are on the treatment page.

A good decision can be to treat, to try a nonhormonal route, to investigate first or to leave a manageable symptom alone. The point is not to reach hormones. It is to reach a plan that fits the evidence and your priorities.

Perimenopause Treatment Questions

Discuss the Options in Context

If your symptoms are changing and you want a clearer sense of what belongs to perimenopause, begin with the hormone therapy page. The perimenopause and menopause treatment page brings the condition, evaluation, fees and connected concerns together in one place.

You do not have to choose a treatment before a consultation. The useful first step is to name the problem clearly and bring your questions. We can then decide whether hormones, a nonhormonal option, local treatment, further investigation or no treatment is the sensible next move.

Like what you read? Share with your friends!
Scroll to Top